Karolinska Institutet
Browse

Extracorporeal membrane oxygenation (ECMO) for the treatment of cardiogenic shock : identification of pre-implant outcome predictors

Download (1.86 MB)
thesis
posted on 2024-09-02, 17:33 authored by Thomas FuxThomas Fux

Background: Refractory cardiogenic shock (RCS), cardiac arrest (CA) and postarrest cardiogenic shock (CS) are associated with high mortality. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used and can offer acute cardiopulmonary life support in this critically ill population but selection of VA-ECMO candidates remains challenging. There are limited data on which pre-VA-ECMO variables that predict outcome.

Aims: To identify pre-VA-ECMO predictors for 90-day mortality in Study I unselected, Study II postcardiotomy and Study III non-surgical patients with RCS, and Study IV in patients with CA or postarrest cardiogenic shock prior to VA-ECMO were studied.

Methods: Study I-IV were observational and retrospective. Study I included 181 mixed patients with RCS, Study II 105 patients with refractory postcardiotomy CS, Study III 76 non-surgical patients with RCS and Study IV 72 patients with CA or postarrest CS prior to VA-ECMO cannulation. The association between pre-implant variables and all-cause mortality at 90 days was analyzed with uni- and multivariable logistic regression.

Results: Study I. Main etiologies of RCS were post-cardiotomy failure 58%, acute myocardial infarction 22% and other medical etiologies 20%. Median duration of VA-ECMO support was 7 days (interquartile range [IQR]: 3-13). The 90-day overall mortality was 54%. Arterial lactate (odds ratio [OR] per unit: 1.14; 95% confidence interval [CI]: 1.06-1.23; p <0.001), number of inotropes and vasopressors (OR per agent: 1.58; 95% CI: 1.13-2.21; p = 0.008), and ischemic heart disease (IHD), (OR: 2.90; 95% CI: 1.31-6.39; p = 0.008) were independent predictors of 90-day mortality. Study II. Main surgical subgroups were single non-CABG 29%, isolated CABG 20%, 2 and 3 concomitant surgical procedures, 31% and 20%, respectively. Median duration of VA-ECMO was 7 days (IQR: 3-14). The 90-day overall mortality and in-hospital mortality was 57% and 56%, respectively. Arterial lactate (OR per unit: 1.22; 95% CI:1.07-1.40; p = 0.004), and IHD (OR: 7.87; 95% CI: 2.55-24.3; p <0.001) were independent predictors of 90-day mortality. Study III. Main etiologies of RCS were acute myocardial infarction 51% and acute heart failure of other etiologies 49%. Median duration of VA-ECMO was 5 days (IQR: 2-11). The 90-day overall mortality was 49% and in-hospital mortality was 50%. Arterial lactate (OR per mmol/L: 1.15; 95% CI: 1.06-1.24; p = 0.001) and number of inotropes and vasopressors (OR per agent: 2.14; 95% CI: 1.26-3.63; p = 0.005) were independent predictors of 90-day mortality. Study IV. Out-of-hospital CA occurred in 12% of the patients. Initial cardiac rhythm was non-shockable in 57%, and shockable in 43% of the patients. Median cardiopulmonary resuscitation duration was 21 minutes (IQR: 10-73, range:1-197). No return of spontaneous circulation (ROSC) was present in 64% and postarrest CS in 36% of the patients at VA-ECMO cannulation. Median duration of VA-ECMO was 5 days (IQR: 2-12). The 90-day overall mortality and in-hospital mortality were 57%, respectively, and 53% died during VA-ECMO. All survivors (43%) had cerebral performance category score 1-2 at discharge to home. Initial non-shockable CA rhythm (OR: 12.2; 95% CI 2.83-52.7; p = 0.001), arterial lactate (OR per unit: 1.15; 95% CI: 1.01-1.31; p = 0.041), and IHD (OR: 7.39; 95% CI: 1.57-34.7; p = 0.011) as independent predictors of 90-day mortality.

Conclusions: Identified independent pre-implant predictors for 90-day mortality after VA-ECMO initiation were in Study I arterial lactate, number of inotropes and vasopressors, and IHD, Study II arterial lactate and IHD, Study III arterial lactate, number of inotropes and vasopressors, Study IV initial non-shockable CA rhythm, arterial lactate and IHD. These predictors are easily available for pre-VA-ECMO risk prediction.

List of scientific papers

I. Fux T, Holm M, Corbascio M, van der Linden J, Lund LH. Pre-Implant Outcome Predictors in Patients with Refractory Cardiogenic Shock supported with VA-ECMO. J Am Coll Cardiol. 2017 Oct 17;70(16):2094-2096.
https://doi.org/10.1016/j.jacc.2017.08.033

II. Fux T, Holm M, Corbascio M, Lund LH, van der Linden J. Venoarterial Extracorporeal Membrane Oxygenation for Postcardiotomy Shock: Risk Factors for Mortality. J Thorac Cardiovasc Surg. 2018. [Accepted]
https://doi.org/10.1016/j.jtcvs.2018.05.061

III. Fux T, Holm M, Corbascio M, Lund LH, van der Linden J. VA-ECMO Support in Non-Surgical Patients with Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors. Artificial Organs. 2018. [Accepted]
https://doi.org/10.1111/aor.13331

IV. Fux T, Holm M, Corbascio M, van der Linden J. Cardiac Arrest Prior to Venoarterial Extracorporeal Membrane Oxygenation; Risk Factors for Mortality. [Submitted]

History

Defence date

2018-11-02

Department

  • Department of Molecular Medicine and Surgery

Publisher/Institution

Karolinska Institutet

Main supervisor

van der Linden, Jan

Co-supervisors

Lund, Lars H.; Corbascio, Matthias

Publication year

2018

Thesis type

  • Doctoral thesis

ISBN

978-91-7831-190-3

Number of supporting papers

4

Language

  • eng

Original publication date

2018-10-11

Author name in thesis

Fux, Thomas

Original department name

Department of Molecular Medicine and Surgery

Place of publication

Stockholm

Usage metrics

    Theses

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC